Dr Francis - Heart health throughout pregnancy

Johns Hopkins Medicine
6 followers
1 Video View·Jan 8, 2025
Joining the wrong meeting link and the slight tech issues but we're ready now. So please do put
questions in the chat as we go along or if you want to raise your hand hopefully someone can alert
me if I've missed a sort of raised hand or you know unmute yourself if you have questions on the
way through. I'm very happy to pause and sort of discuss as we go through. I'm planning to talk,
I know we've got about an hour, I'm not planning to talk at you for that long so hopefully talking
about sort of 30 max 40 minutes to leave plenty of time for questions at the end. So I'm Dr.
Fran Conty-Ramsden and I've got a couple of different hats and a couple of declarations
so I'll just go through those now. So I'm a medical doctor and obstetrician and gynaecologist
registrar based at Guy's and St. Thomas Hospital. I'm also an academic, I'm in the final year of my
PhD at King's College London in the maternal hypertension group. I recently started as chief
medical officer at Meggie Healthcare and I'm also doing some advisory work at the Nexus which is
why I'm here and just to say that all my, most of my diagrams today have been courtesy of BioRender
which is amazing. It's the first time I've used it this time, I got it through the university.
So I wanted to start with why I'm focusing on cardiovascular health in women and I think most
of us probably will have seen the publication of the McKinsey report earlier this year which
did focus on women in the US but I think it's got, you know, really international messages. So
we know that cardiovascular disease is the number one cause of death in women
but the women say face systematic barriers both in terms of diagnosis and treatment so they're less
likely to be diagnosed, their symptoms are more likely to be misattributed to other problems,
they're less likely to receive the appropriate investigations if they present with symptoms of
cardiovascular problems and they're actually also undertreated so they're less likely to get the
correct medication at the right time. I think probably again, I imagine not news to most of
you on this call but certainly I think would be in other audiences is that women are really
underrepresented in research and this includes cardiovascular research and this is from the
animal models to clinical trials. So I work primarily in sort of clinical trial space but
even animal models, so you know when people say, oh we looked at this pathway or these drugs in
mice, the majority of mice are male mice because it's harder to account for the cycling in the
female mice. So even our sort of preliminarily used lab data, there's a sex bias and that goes
all the way through to clinical trials and there's a real funding problem. So compounding the fact
that we have less data, we know that women are having poorer care and outcomes and only one
percent of healthcare research innovation funding goes to female specific conditions. It's a really
kind of perfect storm in terms of sex biases in medicine. Just in case, the term cardiovascular
disease might be new to you today, I just wanted to talk a little bit more about what I mean by
that. So sort of cardiovascular means essentially the heart and the vascular system. So the nice
picture in the middle shows you your heart and then in these red tubes are your arteries, so
like the plumbing that takes the oxygenated blood, so the blood that's had the oxygen from the lungs
or pumps it and then gets pumped all around the body through this tube system. So when we talk
about cardiovascular disease, we can think about both some of the sort of the risk factors and
physiological processes. So one of the key things we think about is high blood pressure,
so hypertension. Then we can think of the sort of the processes going on in the vessels
themselves. So in the bottom right there you can see, you've got to imagine if we took one of those
vessels and we sort of cut it in half and we were looking down the tube, you can see
there's a muscular wall and an outer layer and that kind of yellowy blotchy stuff is built up
of plaque, so sort of inflammatory plaque that both narrows the diameter of what the blood vessel
can actually flow through but also can actually be so unstable that it ruptures and this is
what often happens in the cases of sort of heart attacks and strokes. So we can think about some of
these sort of, I guess let's call them precursors, so things like hypertension, things like
vessel disease and then we can think about actually the sort of the organ damage which causes
the diseases that we know about, so for example heart attacks, so it's when the blood supply to
your heart is compromised and strokes, when the blood supply to your brain is compromised and then
also actually clots in the vasculatures themselves, so peripheral vascular disease.
So it's actually a really wide spectrum of issues and that it encompasses a lot of different
diagnoses as well as sort of the pathophysiological processes that are occurring to the heart
and the vessels themselves and women's physiology obviously is unique and different
and really varies across the life course. So we can see here, you know, from baby
going through puberty to an adult woman who would be cycling, you know, if she's having
regular cycles and depending on what hormonal medication she may be taking then obviously
some women will become pregnant and then later in life women will transition to the menopause
and these unique biological differences throughout these different life stages
actually affect cardiovascular health and we're really sort of, I would say we're just
sort of just starting to understand, there's still areas that need a lot more research but
we're just starting to understand some of the nuance here in terms of what it means both for
sort of prediction and treatment of disease. So what I'm going to focus on today is pregnancy
and, you know, there is a lot, obviously you can see this is a huge topic and I know Leo's keen to
put more webinars on in the new year. I've chosen pregnancy because that's what my research is based
in so, you know, I could talk about this all day but, you know, if there's interest in other
topics, particularly, you know, female specific health conditions, menopause and cardiovascular
health, please do put comments and suggestions and we can definitely pick those up putting on
other webinars in the new year but today I'll be talking about pregnancy. So we can think of
pregnancy as a stress test and I could give this talk about actually a whole range of different
sort of organ systems. I'm happening to talk about the cardiovascular system today but I could talk
about the endocrine system and diabetes, I could talk about the kidneys. What I want you to kind
understand is, I guess, what the demands of pregnancy and how we can sort of conceptualise
pregnancy as a stress test. So I'm going to just walk you through a couple of the changes that
occur from sort of the beginning to the end of pregnancy so you get a flavour of what the body's
having to adapt to from a cardiovascular perspective. So when a woman is not pregnant,
the uterus is small, you know, the thing we get taught to show is to kind of bunch up your hand
like this and your womb is about the size of your kind of your hand in this kind of position,
kind of like a medium-sized pair, obviously, assuming you don't have pathology such as
fibroids etc. It weighs about 70 grams and you're having a blood flow of less than 100 mls per
minute. By the time you get to full term with a pregnancy, the uterus is the size of a large
watermelon and it weighs almost a kilo and that's just the uterus. So we're not talking
the additional weights there of a baby, the placenta and the amniotic fluid and the blood
supply is getting close to, you know, over 700 mls, close to one litre a minute. So you can
imagine in order to support both the growth and development of the placenta, the baby and the
uterus itself, there has to be an enormous adaptation in your cardiovascular system in
order to do that because actually when you're not pregnant and if you are menstruating,
you are cycling, the last thing you want to do is to bleed really heavily, right? So it doesn't
make sense for loads of blood to be going to your womb because you risk bleeding out every month and
evolutionarily that wouldn't have worked. So you don't want lots of blood going to your womb when
you're not pregnant but as soon as a pregnancy occurs, that whole system needs to shift and you
need to be able to adapt to this enormous growing demand over hopefully the next nine months.
To achieve this, the heart and the vascular system have to undergo a huge amount of
what's called remodelling and cardiovascular adaptations, it's adapting to this changing
demands and needs. And the way that the heart and the vascular system achieve this is by
a number of different things but I think one of the ways I like to think about it is that it's
plumbing. So imagine your heart is like the pump and then all those vessels that we saw a couple
of slides ago are the tubes that will be going to your radiators or whatever you might
conceptualise in the planning system. What you need to happen is for those tubes to get much bigger
and wider so that more blood can flow. So if the tubes stay really narrow you can imagine that
the motor's going to have to work hard to pump that blood around. What you're aiming for is a
low resistance, so nice open arteries, high flow. So you want a nice big tube and you want to be
full of blood. So actually most of these changes happen in the first trimester which is often why
women feel absolutely appalling and dizzy in the first trimester because these changes are all
happening very early on. But what you see is that the amount of blood you have, the volume of blood
increases, you start to retain water and increase how much blood you have and the diameter, so the
size of your blood vessels, they start to relax and they get a lot bigger. And this means that
you go to this really high flow, low resistance circulation so you can basically get loads of
blood around your system and that's ideal to nourish the growing foetus and establish the
placenta and the womb. And this actually of course means that your heart has to work harder, it's
pumping more blood around and your vessels are changing. And particularly also changing other
vessels that supply the uterus, the womb, and I'll talk about that a little bit more in a couple of
slides from now, but they've got to go from being something that doesn't let that much blood go to
the uterus because you don't want, like I said, you want to lose a lot of blood every time that
you have a period if you are cycling, but that needs to change when you become pregnant. So
hopefully that gives you an idea of the scale of the changes of the cardiovascular system.
So the question is, you know, what happens if, when, what kind of cardiovascular diseases do
we see in pregnancy? And the reason why I put it in the context of the stress test is because
if you have a system that for whatever reason, maybe you're already slightly higher risk before
you went into pregnancy, or maybe some of this early adaptation to the changes in your plumbing
doesn't work in the way it should do, particularly in the placenta. As a result, what we see is
high blood pressure, so hypertension in pregnancy. And there are two main categories. I don't want
to delve into too much detail here because I think the majority of people aren't from a medical
background, but there are two broad camps. So one is blood pressure problems alone, and that
encompasses both women who, because there are a number of women who have got high blood pressure,
so chronic hypertension, actually before they fall pregnant, obviously that will continue through the
pregnancy. So they've already got that. You know, we know that there's that risk in their cardiovascular
system, but some women for the first time in pregnancy, their blood pressure will go up. So
I had totally normal blood pressure before pregnancy, but it will go up. When it's blood
pressure alone, it's called gestational hypertension. When we see the blood pressure
go up and any other organ involvement, the classic one is that the kidneys start to become a little
bit leaky and you get protein in your urine, which is called proteinuria. That's called preeclampsia.
And I'll just talk a little bit more about preeclampsia because that's one of the things
that I'm going to focus on in terms of how this all becomes relevant in terms of longer life
cardiovascular disease, is that preeclampsia is currently conceptualised as a disease of the
placenta. So when I was talking about this process of adaptation, one of the key changes that needs
to occur is that the arteries, so the vessels that are bringing the blood full of oxygen from your
heart to your uterus when you're pregnant, they need to go from being tight and narrow to becoming
wide and letting lots of blood to flow through. We don't understand why this doesn't always occur
well, but we think this is one of the main issues that may go wrong in women who are going to
develop preeclampsia later in their pregnancy. So for some reason, maybe they had underlying issues,
maybe it's something to do with that specific pregnancy, that process doesn't occur. And what
ends up happening is the placenta doesn't form as well as it could do. And instead of getting
lots of blood pumping through, you have limited blood coming through. So it's suboptimal blood
flow to the uterus and the growing baby. And as you can imagine, the baby has growing needs as
the baby gets bigger and bigger and bigger. And so the woman's body tries to really compensate
by working harder and harder and harder. And the placenta comes under a lot of stress.
And what happens then is that actually that leads to release of chemicals into the woman's
blood system, which can lead to organ damage across the body. And I don't want to go into a
lot of detail here, and I'm very happy to answer more questions if people are interested, but
that's just to give us a flavour of some of the physiology of what's happening.
And you might think, gosh, this all sounds not great. And how common is this? And the answer
is it's really common. So the number out there is that one in 10 women experience high blood
pressure in pregnancy. And actually, looking at some population data from our local South
London cohort, it's probably higher than that actually, certainly in some settings.
And why does this matter? And it matters because we're getting increasingly good data now to show
that pregnancy complications are associated with medium and long term health. So like I said,
I could have been giving this talk about a whole range of different organs or diseases,
and the story would be similar. I guess the fundamental message I'm trying to get across is
pregnancy is this enormous physiological undertaking. So if you've got a propensity
to diabetes, if you've got a propensity to your kidneys not working as well as they could do,
if you've got a propensity to heart disease and cardiovascular disease,
pregnancy kind of unmasks that because it's such an enormous strain that your body is going through.
And obviously, for a lot of people, it's a smooth sailing journey, and that's wonderful.
But a significant proportion of women will experience a complication in their pregnancy.
And this is some of the latest data. So this is the paper from January this year. And what these
authors did is that they did an update of what's called systematic review and meta-analysis. And so
this is when they've searched all the available academic literature, they apply stringent criteria
on studies that they think are good enough to include in a synthesis of this data, so putting
numerous studies together. And then rather than relying on just one study, you put all of the
studies together to try and come up with a global estimate, so estimates of risk across multiple
studies. And that tends to give you much better accuracy and can also help you understand where
gaps in understanding might be. And this was a study that we wrote an editorial on, and it was
well-conducted. And the first time that actually they've been able to adjust for quite a lot of
confounders, so things like, you know, BMI, age, pre-existing diabetes, you know, a lot of the
quality of the studies is gradually getting better. And what I want you to take away from this table
is what's called the adjusted risk estimates. So this is the risk of these cardiovascular
outcomes. You can see cardiovascular death, coronary arteries, heart failure and stroke,
so really significant clinical outcomes. And we're comparing the risk of a woman who's
experienced preeclampsia in her pregnancy versus a woman who did not experience preeclampsia in her
pregnancy. And you can see that for all of these outcomes, there's, apart from stroke actually,
it's the adjusted risk, so accounting for BMI, accounting for age, so some of those, you know,
the really strong risk factors that we know about, there is an independent association between
preeclampsia and these outcomes. So we know that women who've experienced preeclampsia in their
pregnancy, and the same holds true for the other hypertensive disorders, so things like gestational
hypertension, but to a lesser degree, so the, you know, the multiple of the risk isn't quite as high,
preeclampsia is the strongest risk, they are more likely to, much more likely to develop these
cardiovascular outcomes. But actually what really was fascinating to me is when is this happening?
And what they actually showed in a really nice sort of analysis of the follow-up periods,
was that this risk is there from the early years postnatally, so that those elevated risks are
apparent in the first one to three years postpartum, and the risk remains up to almost 40 years of
follow-up. So, you know, it's, something's happened, either that the pregnancy has unmasked,
or that the development of the disease itself has done something to this woman's cardiovascular
system, which means that it's putting her on a different trajectory postnatally in terms of her
risk of cardiovascular disease. And this is the editorial that we wrote to accompany this article
with two of my wonderful bosses, Dr. Kate Bramham and Dr. Tony de Marval,
and to really put this in context, you know, certainly, maybe me a few years ago, you think
like, who do you think of when you think of cardiovascular disease? You think of like old
people, right? You think of maybe your grandma or your grandpa, who's had a stroke, or a heart
attack. We don't really think of it as a disease of young people. But what's really quite scary
is that these events are happening in young women. So the average age of a first pregnancy
in Europe in the US is currently 30, it's going up all the time. And there was a really great
electronic health record study, and the references is there for those interested, published in
circulation, where they looked at women who'd experienced preeclampsia. And when they were
these cardiovascular events, 65% of them were under the age of 40. So these women are not
experiencing these events, you know, 20 years later, it's happening whilst they're young.
And particularly for someone who's got children, you know, this is, I find this, you know, it's one
of the reasons I do what I do is that it's really motivating that we need to do something better
here to really try and change that trajectory. So can we change it from the trajectory that
these women are on to a better trajectory? And I just want to point out here that all of this
data, because it's not trial data, we're not randomizing women to one group or another,
it's very difficult to infer what comes first. So we don't know, do women who have preeclampsia,
do they have higher risk of cardiovascular disease, because actually, even pre-pregnancy,
there was some, they already had risk factors, and that pregnancy has unmasked it, or is it the
disease itself, we can't unpick it from these data. But in a way, that matters less to me from
a pragmatic perspective, because the message is very clear, we need to work out how to optimize
health postnatally, because essentially, pregnancy is acting as a screening test, it's telling us,
these women are at higher risk of this. And like I said, we could we could talk about other
disease areas. So let's look at what current sort of state of the art clinical practice guidelines
in the UK say. So these are the NICE hypertension and pregnancy guidelines in 2019. And essentially,
there is a research recommendation on what interventions we should put in place in the
postnatal period, because there's no data. So we don't know, you know, if we control blood pressure
better, if we give statins, if we put, you know, if we give women lifestyle, and dietary advice,
we don't know if any of these, we don't have trial data to say, this will actually reduce
women's risk in the long term. So essentially, the approach in current guidelines is to,
for women to discuss their risk with a specialist or the GP. And you can see here,
there's a NICE table, which gives the cardiovascular outcomes on the left. And you
can see there's, you know, very specific numbers that you can give women about what their risk is.
And they say, you know, try and reduce cardiovascular risk. So that may include stopping
smoking, healthy lifestyle and weight, and they recommend pre-conceptual counselling for future
pregnancy in a certain scenario. But I want to ask, actually, what happens currently in clinical
practice. And the reality is that the majority of hospitals in the UK, they don't have a specific
pregnancy hypertension service. That means they don't have specialists who know a lot about blood
pressure in pregnancy. And most women, therefore, won't have specific follow up with their pregnancy
team. Most women will be referred back to their GP. So we have to ask the question,
what do health professionals know about the intersection of pregnancy and cardiovascular
health? And this is a NICE study, again, published this year, where they surveyed midwives,
obstetricians, cardiologists and general practitioners. And there was some knowledge
around understanding preeclampsia and the risk of future heart disease. But other than obstetricians,
so pregnancy specialists, who, like I said, are actually very unlikely to see women postnatally
outside of sort of tertiary centres, so like specialist hospital settings. Most other clinicians
never counsel patients. So midwives don't counsel, they would only counsel 25%. Cardiologists,
the heart doctors, they would only counsel 25% of the time. And GPs do a little better, actually,
so 40% of them would counsel. But still, most, and this is certainly something that I think is
borne out in clinical practice, is that after delivery, these women kind of go back to the
community, and then we'll see them maybe five, 10, 15 years later, in a kidney failure clinic,
or in a heart failure clinic. And so there's a real missed opportunity. And that's because
we don't have the knowledge and actually the research data to know what should we be doing
better. There are, having painted quite a negative picture, there are some very positive
moves, and I think there's a real societal awakening, which I hope is really going to
take off in the next few years, that we need to research sex differences, we need to understand
all health conditions in the lens of how does this present, what's the right risk stratification,
what's the right treatment for women as opposed to men, so moving away from this male default.
And there are some early positive moves in this direction, and this is one that caught my eye
this year, which is something called the Q-Risk score. And I think for the GPs on the call,
they'll be very familiar with Q-Risk. So Q-Risk is an algorithm that's used if you're invited for
your well woman, or perhaps somebody you know, their well man check, what they tend to use
in terms of cardiovascular disease risk is using something called the Q-Risk calculator. You can
actually just search it online and input your data there if you're interested to see how you fare.
And this helps doctors make a decision about whether we should be thinking about prescribing
drugs to prevent cardiovascular disease in people that have never had the disease before,
or actually to help optimise health in individuals with cardiovascular disease.
And it'll be no surprise to most of you that this has been historically a totally male dominated
tool. And up until this paper, there had been no female specific risk factors, which just doesn't
make any sense. And this, but encouragingly, and this was in Nature Medicine, you know,
this is the first time that they've actually looked at female specific risk factors for
cardiovascular disease risk prediction. And what they found was two novel risk factors in women,
and preeclampsia was one of them. And interestingly, postnatal depression was the second.
So people are starting to wake up to the fact that actually, we need to start looking at these
sex differences, and then integrating them into our clinical tools. And I think this is really
exciting that something that's used every day by GPs, hopefully, you know, the next iteration,
obviously, it's only been published this year, is going to start to include female specific factors,
and that will build in years to come. So then I want to move on to the fourth trimester.
And that's because it's been a little bit of early data, and it's still quite early,
and it's too early to draw conclusions, but about whether there might be a golden window
of opportunity. So the fourth trimester is sort of the postpartum period. So usually,
we sort of think about six weeks up to 12 weeks after delivery. And the reason why I think a lot
of us in sort of academic pregnancy research are excited is because of this study that was
actually published back in 2018. And what they did in this study was that they, it was a small
randomized control trial. So they did randomize women to two groups, an intervention group and
a control group. And the intervention that they were testing was self-management of blood pressure.
So they essentially gave women a blood pressure machine that they could use at home,
and they gave them an app to record their blood pressure measurements. And then there
was just a very simple sort of visual tool to say, okay, your blood pressure is doing great,
you know, recheck tomorrow. Oh, that's a bit high, you know, speak to your doctor. So nothing
particularly fancy. And this was a feasibility study, so it wasn't big enough to draw definitive
conclusions. But they found that, so the duration of the intervention was six months. So the women
either had the app and the blood pressure machine for six months, or they were just sort of released
into the community with the usual advice of, you know, your midwife will check your blood pressure,
then see your GP at six weeks. And they did find that the women in the intervention group had lower
blood pressure at six weeks, also lower blood pressure at six months. But what's really sort
of amazing, and I think a lot of us started to think, you know, how is this working and have we
got a golden opportunity to intervene, was that those changes in blood pressure persisted at three
to four years of follow-up, even if women were off drugs, even if women had been off drugs since
five weeks postnatally. So if we go back to thinking about cardiac remodelling in early
pregnancy, obviously, when you deliver the baby, the reverse process has to occur. So you have to
go from all those adaptations to sustain one and a quarter human beings back to one again.
And actually, there's a lot of data out there showing that, again, the heart and the vessels
really change. And the heart wall, you know, the thickness of the wall, the structure of the wall
of your heart, all of that is changing as a result of delivery, and then all of the hormonal changes
in the postpartum period. So it's possible that we actually, that there's a window where you can
actually really modify someone's heart structure, which is kind of mind-blowing that there may be
this sort of, it's almost sort of, you know, being able to exploit this unique physiology in women,
that it's like there's a chance maybe to remodel things for the better. And like I said,
that's a really exciting area where I think, you know, postnatal care in the UK would be another
discussion, but it is minimal. And I just think there's so much that could be done here to support
women just more generally postnatally, but also really to think about how we might be able to
help women to optimise their medium and long-term health. So I'll talk a little bit about a couple
of upcoming studies in this space. So the feasibility study that I talked about is now
turned into the full-scale randomised controlled trial, which is SNAP2, and they've been recruiting
for three months. So hopefully we'll get, you know, proper, good answers in a couple of years'
time, which is years in clinical trials world, I'm afraid. It takes a long time to get these
studies done and the results published. And then one of the projects that I'm leading on is using
how to describe it, sort of a data lake. So where all the data available in a hospital,
so all the sort of the notes, the discharge summaries, the drug data, the scans, the blood
tests, it's all in this secure sort of clinical environment. And as researchers, we can start to
use AIs, LLMs, so large language models, to actually process this data to give us diagnosis.
So, you know, who's had pre-eclampsia, who hasn't, what do their blood tests like, and we're hoping
to use that to really understand who is at the highest risk in the post-natal period and start
a pilot service. So we're actually on the basis of the modelling of the data, we start to invite
women back to clinic and see if we can help improve their cardiovascular health, which is
really exciting. So really trying to work in this space to change outcomes. So I think that's
everything that I wanted to talk about. So just a quick recap. So we've talked about what cardiovascular
disease is. So it encompasses both sort of conditions like blood pressure and changes in
your vessels, but also kind of the organ disease as a result of those processes. So heart attacks
and strokes, heart failure, et cetera. We talked about what kind of cardiovascular diseases occur
in pregnancy. And then we've talked about the link between the two and with pregnancy acting as
a sort of stress test for cardiovascular disease. But like I said, it's true of many, many organ
systems, not just high blood pressure and cardiovascular disease. And what we're really
trying to work on now in the academic community is what can we do about this? So we've got the
data, we know that the risk is there. We have enough studies now to say this with confidence.
This is not just because, it's not because of bias or confounding, this is an independent
association. But what we need to find out is what we can do about it to really try and change
women's lifetime trajectories in terms of cardiovascular disease, which is so important,
given that this is the number one cause of death and also living years in disability as well.
I appreciate this might all sound quite doom and gloom, particularly if you've been unlucky enough
to experience one of these complications. So I just wanted to put a slide in and I'm very happy
to take more questions on this. Like I said, we don't have the answers now. We don't know,
I can't say definitively, you do X, Y, Z and it will reduce your risk. But I think,
you know, knowledge is power, education is really important. So I think just, you know,
understanding these concepts, you know, telling your friends and family, like if you know someone
who's had preeclampsia, like do they know about this? Have they checked their blood pressure?
And the thing about hypertension is that it's totally silent. So if you have high blood pressure,
you may not know for years. And that's why pregnancy is also one of the times that we
discover that women have high blood pressure because they're in their 20s or maybe their 30s
or maybe they're in their 40s. And, you know, unless you've been to the GP for other reasons,
you may never have had your blood pressure taken. And so we actually pick up hypertension in
pregnancy. But particularly if you've had high blood pressure in your pregnancy, measure your
blood pressure postnatally. And I know that I meant to add to the slides that both action on
preeclampsia in the UK and the Preeclampsia Foundation in the US have got some great
resources as well to really help you to advocate for yourself going to see your GP or similar.
And then think about the risk factors that you may be able to modify. It's all the sort of the
classic things that we hear about time and time again. So things like BMI, smoking, pre-diabetes
and diabetes, managing high blood pressure if you do have hypertension, but also things like
stress and diet. You know, I think that's where it's really interesting to see companies like
Nexus where what does more holistic management do? So with more holistic thinking about, you know,
diet, exercise, as well as your blood pressure medication potentially, you know, how much added
value can we add? So hopefully this is a space that we'll be getting more data in the coming
years. So thank you very much. I'd like to acknowledge my academic supervisors. I'm funded
by the Medical Research Council and I put a QR code there to my LinkedIn profile, which links to
my Orchid ID for my publications. And obviously, hopefully all the references will be available to
you on the recording. And I'm sure we can circulate the slides as well. Thank you so much, Fran.
That was amazing. I have so many questions, but let's probably not be selfish and open it up. So
yeah, who's got some questions for Fran or if they would, yeah, if they'd rather
ask it when the recording has ended, feel free to let me know in the comment. We'll answer
whoever's happy to share now, and then I'll turn the recording off in a moment. Feel free to either
unmute yourself or drop them in the chat, whatever you prefer. As I'm just looking through the chat,
do we have any additional card bust margin or follow up, given that they are at higher risk?
Yes, I think, so Catherine asked about whether women get additional monitoring or follow up.
And I think you said that this is your next point. But yeah, just to recap that essentially,
we, because we don't have data to know what interventions work, currently in the UK,
the advice is to kind of advise women that they are at higher risk. And then it's sort of very
general kind of lifestyle modification, but there's no specific interventions in the postnatal
period and or kind of a schedule of follow up. The one thing that most places recommend is a
one year blood pressure check with your GP. But that's actually an ongoing piece of work to see
how many women who have high blood pressure in pregnancy go for that one year checkup.
And given that, you know, even at the I think the six weeks postpartum checkup is,
I think about 60% of women make it. And, you know, I imagine that there's a big gap there in
terms of who actually gets the follow up that we would, even this very basic level, be advising
I will stop the recording.
